Search Login Register

Xeroderma Pigmentosum (Kaposi's Disease) Summary

Description: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Also Known As: Kaposi's Disease; Kaposis Disease; Kaposi Disease

Networked: 1684 relevant articles (23 outcomes, 85 trials/studies) for this Disease

Key Drugs and Agents for Xeroderma Pigmentosum

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Isotretinoin (Accutane) : 5 outcomes 2 studies in 13 results : FDA 6 Generic
  2. DNA (Deoxyribonucleic Acid) : 3 outcomes 17 studies in 564 results : IBA
  3. DNA Adducts : 2 outcomes 2 studies in 24 results : IBA
  4. Retinoids : 2 outcomes 1 study in 9 results : IBA
  5. Acitretin : 2 outcomes 1 study in 4 results : FDA 1
  6. Codon (Codons) : 1 outcome 7 studies in 23 results : IBA
  7. Platinum : 1 outcome 6 studies in 20 results : IBA
  8. Bleomycin (Blenoxane) : 1 outcome 2 studies in 11 results : FDA 7 Generic
  9. 4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide) : 1 outcome 1 study in 14 results : IBA
  10. Etretinate : 1 outcome 1 study in 8 results : FDA 1
Show All >>

Diseases Related to Xeroderma Pigmentosum

  1. Skin Neoplasms (Skin Cancer)
  2. Neoplasms (Cancer)
  3. Basal Cell Nevus Syndrome (Gorlin Syndrome)
  4. Head and Neck Neoplasms (Head and Neck Cancer)
  5. Squamous Cell Carcinoma (Epidermoid Carcinoma)
Show All >>

Key Therapies for Xeroderma Pigmentosum

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 outcomes 9 studies in 26 results
  2. Chemoprevention : 2 outcomes 1 study in 6 results
  3. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 1 outcome 1 study in 2 results
  4. Transplants (Transplant) : 1 outcome in 20 results
  5. Oral Administration : 1 outcome in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.